Poor Compliance Is a Major Factor in Unstable Outpatient Control of Anticoagulant Therapy

Summary

Control of oral anticoagulant therapy in outpatients is often unsatisfactory. The contribution of poor compliance with prescribed warfarin to unstable anticoagulant control was investigated prospectively using low-dose phenobarbitone as an indicator of compliance in 30 out-patients, 15 with stable and 15 with unstable control. Following entry to the study, there was no significant change in anticoagulation (p = 0.36) in the group with stable control. In the group who previously had unstable control, there was a significant change in INR (p = 0.0045) and anticoagulant control greatly improved. It appears that the considerable fluctuation in INR seen in many of the latter patients before the study was due to poor compliance and that entering them into the study modified their behaviour. Two patients in this group who continued to have unstable anticoagulant control were shown to be poorly compliant using the phenobarbitone indicator. The results suggest that, in outpatients, poor compliance is the major cause of unstable anticoagulation with warfarin.

Keywords

Warfarin therapy - Unstable anticoagulation - Poor compliance

• References

• 1 Duxbury BMcD. Therapeutic control of anticoagulant treatment. Br Med J 1982; 284: 702-704
• 2 McInnes GT, Helenglass G. The performance of clinics for outpatient control of anticoagulation. J R Coll Phys 1987; 21: 42-45
• 3 Harries AD, Birtwell AJ, Jones DB. Anticoagulant control. Lancet 1981; i: 1320
• 4 Sixty Plus Reinfarction Study Research Group. A double-blind trial to assess long-term anticoagulant therapy in elderly patients after myocardial infarction. Lancet 1980; ii: 989-994
• 5 Standing Advisory Committee for Haematology of the Royal College of Pathologists. Drug Interactions with coumarin derivative anticoagulants. Br Med J 1982; 285: 274-275
• 6 Paterson CE, Kwaan HC. Current concepts of warfarin therapy. Arch Intern Med 1986; 146: 581-584
• 7 O’Reilly RA, Aggeler PM, Silvija Hoag M, Leong LS, Kropatkin ML. Hereditary transmission of exceptional resistance to coumarin anticoagulant drugs. N Engl J Med 1964; 271: 809-815
• 8 Holford NH G. Clinical pharmacokinetics and pharmacodynamics of warfarin. Understanding the dose-effect relationship. Clin Pharmacol 1986; 11: 483-504
• 9 Murray B, Coleman R, McWaters D, Ludden T, Mungall D. Pharmacodynamics of warfarin at steady state. Ther Drug Mon 1987; 9: 1-5
• 10 Bentley DP, Backhouse G, Hutchings A, Haddon RL, Spragg B, Routledge PA. Investigation of patients with abnormal response to warfarin. Br J Clin Pharmacol 1986; 22: 37-41
• 11 Pearson RM. Who is taking their tablets?. Br Med J 1982; 285: 757-758
• 12 Feely M, Cooke J, Price D, Singleton S, Mehta A, Bradford L, Calvert R. Low-dose phenobarbitone as an indicator of compliance with drug therapy. Br J Clin Pharmacol 1987; 24: 77-84
• 13 Pullar T, Peaker S, Martin MF R, Bird HA, Feely MP. The use of a pharmacological indicator to investigate compliance in patients with a poor response to anti-rheumatic therapy. Br J Rheumatol 1988; 27: 381-384
• 14 Pullar T, Birtwell AJ, Wiles PG, Hay A, Feely MP. Comparison of compliance with tablets precribed to be taken once, twice or three times daily. Clin Pharmacol Ther 1988; 44: 540-545
• 15 Kumar S, Haigh JR M, Davies JA, Roberts BE, Feely MP. Apparent warfarin resistance due to poor compliance. Clin Lab Haematol. 1989. (in press)
• 16 Shinton NK. Guidelines on oral anticoagulation. British Committee for Standardization in Haematology. Haemostasis and Thrombosis Task Force Report. 1984: 5-6
• 17 Recommended Methodology for using WHO International Reference Preparations for Thromboplastin. WHO Geneva 1985; 1211, Geneva 27 Switzerland:
• 18 Gill R, Lopes AA, Moffat AC. Analysis of barbiturates in blood by high-performance liquid chromatography. J Chromatogr 1981; 226: 117-123
• 19 Bjornsson TD, Blaschke TF, Meffin PJ. High-pressure liquid chromatographic analysis of drugs in biological fluids I: Warfarin. J Pharm Sci 1977; 66: 142-144
• 20 Price DE, Mehta A, Park BK, Hay A, Feely MP. The effect of low-dose phenobarbitone on three indices of hepatic microsomal enzyme induction. Br J Clin Pharmacol 1986; 22: 744-747